Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2016, ended Dec 31, 2016 | $164B |
| FY2017, ended Dec 31, 2017 | $186B |
| FY2018, ended Dec 31, 2018 | $154B |
| FY2019, ended Dec 31, 2019 | $205B |
| FY2020, ended Dec 31, 2020 | $240B |
| FY2021, ended Dec 31, 2021 | $228B |
| FY2022, ended Dec 31, 2022 | $147B |
| FY2023, ended Dec 31, 2023 | $174B |
| FY2024, ended Dec 31, 2024 | $142B |
| FY2025, ended Dec 31, 2025 | $108B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $77.3B |
Revenue
By fiscal year, then the trailing 12 months
Show tableHide table
| Period | Revenue |
|---|---|
| FY2016, ended Dec 31, 2016 | $80.7B |
| FY2017, ended Dec 31, 2017 | $85.0B |
| FY2018, ended Dec 31, 2018 | $94.5B |
| FY2019, ended Dec 31, 2019 | $109B |
| FY2020, ended Dec 31, 2020 | $104B |
| FY2021, ended Dec 31, 2021 | $116B |
| FY2022, ended Dec 31, 2022 | $121B |
| FY2023, ended Dec 31, 2023 | $122B |
| FY2024, ended Dec 31, 2024 | $124B |
| FY2025, ended Dec 31, 2025 | $124B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $123B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income | Free cash flow |
|---|---|---|
| FY2016, ended Dec 31, 2016 | $8.68B | $10.6B |
| FY2017, ended Dec 31, 2017 | $22.7B | $11.7B |
| FY2018, ended Dec 31, 2018 | $11.7B | $14.5B |
| FY2019, ended Dec 31, 2019 | $13.1B | $15.7B |
| FY2020, ended Dec 31, 2020 | $10.5B | $15.6B |
| FY2021, ended Dec 31, 2021 | $14.2B | $20.0B |
| FY2022, ended Dec 31, 2022 | $5.37B | $15.8B |
| FY2023, ended Dec 31, 2023 | $15.4B | $16.3B |
| FY2024, ended Dec 31, 2024 | $16.2B | $15.5B |
| FY2025, ended Dec 31, 2025 | $20.0B | $21.9B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $11.3B | $19.7B |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2016, ended Dec 31, 2016 | $3.30B |
| FY2017, ended Dec 31, 2017 | $3.43B |
| FY2018, ended Dec 31, 2018 | $3.81B |
| FY2019, ended Dec 31, 2019 | $5.50B |
| FY2020, ended Dec 31, 2020 | $11.7B |
| FY2021, ended Dec 31, 2021 | $8.71B |
| FY2022, ended Dec 31, 2022 | $4.75B |
| FY2023, ended Dec 31, 2023 | $6.21B |
| FY2024, ended Dec 31, 2024 | $7.32B |
| FY2025, ended Dec 31, 2025 | $9.48B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $7.60B |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.
Show tableHide table
| Period | Total debt |
|---|---|
| FY2016, ended Dec 31, 2016 | $61.0B |
| FY2017, ended Dec 31, 2017 | $64.6B |
| FY2018, ended Dec 31, 2018 | $112B |
| FY2019, ended Dec 31, 2019 | $102B |
| FY2020, ended Dec 31, 2020 | $104B |
| FY2021, ended Dec 31, 2021 | $94.8B |
| FY2022, ended Dec 31, 2022 | $94.8B |
| FY2023, ended Dec 31, 2023 | $97.1B |
| FY2024, ended Dec 31, 2024 | $99.1B |
| FY2025, ended Dec 31, 2025 | $98.9B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $87.4B |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Down 25.3% since FY16.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2016, ended Dec 31, 2016 | 4.75B |
| FY2017, ended Dec 31, 2017 | 4.64B |
| FY2018, ended Dec 31, 2018 | 4.53B |
| FY2019, ended Dec 31, 2019 | 4.55B |
| FY2020, ended Dec 31, 2020 | 4.58B |
| FY2021, ended Dec 31, 2021 | 4.53B |
| FY2022, ended Dec 31, 2022 | 4.22B |
| FY2023, ended Dec 31, 2023 | 3.97B |
| FY2024, ended Dec 31, 2024 | 3.78B |
| FY2025, ended Dec 31, 2025 | 3.60B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | 3.55B |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Bought back | Paid to employees | Sold for cash |
|---|---|---|---|
| FY2016, ended Dec 31, 2016 | $5.35B | $640M | $23.0M |
| FY2017, ended Dec 31, 2017 | $5.43B | $751M | $0 |
| FY2018, ended Dec 31, 2018 | $5.32B | $826M | $0 |
| FY2019, ended Dec 31, 2019 | $504M | $1.02B | — |
| FY2020, ended Dec 31, 2020 | $534M | $1.19B | — |
| FY2021, ended Dec 31, 2021 | $4.67B | $1.31B | — |
| FY2022, ended Dec 31, 2022 | $13.3B | $1.34B | — |
| FY2023, ended Dec 31, 2023 | $11.3B | $1.24B | — |
| FY2024, ended Dec 31, 2024 | $9.10B | $1.29B | — |
| FY2025, ended Dec 31, 2025 | $7.16B | $1.29B | — |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $4.05B | $1.41B | — |
Valuation
At current price- Market Cap
- $77.6B
- P/E
- 6.9×
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 0.6×
- Price / Book
- 0.8×
- EV / EBITDA
- 4.7×
Growth
Trailing 12 months- Revenue (TTM)
- $123B
- Revenue Growth YoY
- −0.2%
- Revenue CAGR 3Y
- 0.6%
- Revenue CAGR 5Y
- 3.6%
- EPS Growth YoY
- −47.5%
- Net Income Growth YoY
- −49.9%
Profitability
Trailing 12 months- Gross Margin
- —
- Operating Margin
- 14.7%
- Net Margin
- 9.2%
- FCF Margin
- 16.0%
- Return on Equity
- 11.9%
Earnings
Trailing 12 months- Net Income
- $11.3B
- EPS (diluted)
- $3.16
- EBITDA
- $33.5B
- Operating Income
- $18.1B
Balance Sheet
As of Sep 30, 2026- Cash and cash equivalents
- $7.60B
- Total Debt
- $87.4B
- Net Debt
- $79.8B
- Total Assets
- $258B
- Total Liabilities
- $165B
- Shareholders' Equity
- $92.5B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $31.7B
- Capital Expenditure
- $12.1B
- Free Cash Flow
- $19.7B
Dividends and risk
Last 12 months- Dividend Yield
- 6.0%
- Dividend / Share
- $1.32
- Beta (5Y)
- 0.69
Every ratio is calculated from the company’s reported figures.